药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Boldenone
Technetium Tc-99m oxidronate
Ferrous sulfate anhydrous can cause a decrease in the absorption of Technetium Tc-99m oxidronate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Phosphate ion
Ferrous sulfate anhydrous can cause a decrease in the absorption of Phosphate ion resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Calcium phosphate dihydrate
Ferrous sulfate anhydrous can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Ferric pyrophosphate citrate
Ferrous sulfate anhydrous can cause a decrease in the absorption of Ferric pyrophosphate citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Sodium tripolyphosphate
Ferrous sulfate anhydrous can cause a decrease in the absorption of Sodium tripolyphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Dipotassium phosphate
Ferrous sulfate anhydrous can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Monopotassium phosphate
Ferrous sulfate anhydrous can cause a decrease in the absorption of Monopotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Ferric pyrophosphate
Ferrous sulfate anhydrous can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Geranylgeranyl diphosphate
Ferrous sulfate anhydrous can cause a decrease in the absorption of Geranylgeranyl diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
OXI-4503
Ferrous sulfate anhydrous can cause a decrease in the absorption of OXI-4503 resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Pyrophosphoric acid
Ferrous sulfate anhydrous can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Geranyl Diphosphate
Ferrous sulfate anhydrous can cause a decrease in the absorption of Geranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Thiopyrophosphate
Ferrous sulfate anhydrous can cause a decrease in the absorption of Thiopyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
3-Aza-2,3-Dihydrogeranyl Diphosphate
Ferrous sulfate anhydrous can cause a decrease in the absorption of 3-Aza-2,3-Dihydrogeranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Incadronic acid
Ferrous sulfate anhydrous can cause a decrease in the absorption of Incadronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Niperotidine
Niperotidine can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Lavoltidine
Lavoltidine can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Lafutidine
Lafutidine can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Roxatidine acetate
Roxatidine acetate can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy.
Boldenone
Metiamide
Metiamide can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy.